Skip to content

Prevalence of COVID-19 (Coronavirus Disease 19) in Pregnant Women on Labor in a Public Hospital in Chile (COroNavirus diSease Covid-19 pandEmic iN ChilE)

Analysis of Prevalence, Pregnancy Outcomes and Sociodemographic Conditions in Women at Labour With and Without Coronavirus 19 Disease COVID-19 in a Public Hospital in Chile

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04551690
Acronym
CONSCIENCE
Enrollment
720
Registered
2020-09-16
Start date
2020-04-15
Completion date
2020-07-15
Last updated
2021-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19, Demography, Labor (Obstetrics)--Complications, Pregnancy

Keywords

Pregnancy, Labor, COVID-19, SARS-Cov2, sociodemographic

Brief summary

This study aim is to assess the prevalence of SARS-COV-2 in unselected pregnant women on labour (or a predictable delivery during next 24 hours), their outcome and sociodemographic conditions.

Detailed description

This is a cross sectional study conducted in Hospital San Juan de Dios, Santiago of Chile. This Hospital attends nearly 4500 births every year. When the COVID-19 pandemia came to Chile, there was no possibility to assess the seroconversion for SARS-Cov2. Currently, it remains unclear the seroprevalence of SARS-Cov-2 in pregnant near to delivery in our country, also its correlation with clinical, perinatal outcomes and sociodemographic characteristics. The project will evaluate these features, collecting nasopharyngeal swab serology in a systematic manner in unselected pregnant women on labor (or a predictable delivery during next 24 hours). Maternal information including clinical data, obstetric history, comorbidities and sociodemographic characteristics acquired from medical records will be correlated to the seroconversion.

Interventions

None listed

Sponsors

Hospital San Juan de Dios, Santiago
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Pregnant women on labor or preterm labor. * Pregnant women who underwent programmed or emergence cesarean

Exclusion criteria

* Stillbirth * Refusal to participate in the study

Design outcomes

Primary

MeasureTime frameDescription
Prevalence of SARS-CoV-2 in pregnant patients on laborThrough study completion, an average of 4 monthsDetermine the prevalence of SARS-CoV-2 in pregnant patients on labor (or a predictable delivery during next 24 hours) with PCR form oropharyngeal swab.
Characterization of clinical features of patients who tested positive for COVID 19.Through study completion, an average of 4 monthsA questionaire was elaborated to quote all of the following symptoms and were checked at the moment of labour by the residents at charge. The questionaire include following symptoms : presence of fever, cough, dyspnea , headache, myalgia, rhinorrhea, odynophagia and anosmia.
Characterization of living conditions of pregnant women with COVID 19Through study completion, an average of 4 monthsNumber of bedrooms and number of persons that sleep in that bedroom.

Secondary

MeasureTime frameDescription
Neonatal hospitalizationThrough study completion, an average of 4 monthsNumber of days requiring hospitalization in the neonatal unit.
Neonatal weightThrough study completion, an average of 4 monthsEvaluate the neonatal outcome classifying the newborn in adequate for the gestational age, large for gestational age or growth restriction for Parkin. Birth weigt is in grams. We use the Neonatal Growth Charts from Chile.
Perinatal outcomesThrough study completion, an average of 4 monthsDescribe the perinatal outcomes of the newborn specifying the Apgar score at delivery.Apgar scores goes form 0 to 10.

Countries

Chile

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026